Back to search

National and Kapodistrian University of Athens

Ο τόνος του συμπαθητικού νευρικού συστήματος ως προγνωστικός δείκτης καρδιαγγειακής νοσηρότητας και θνητότητας σε ασθενείς με έμφραγμα του μυοκαρδίου χωρίς απόφραξη στεφανιαίων αγγείων (MINOCA)

Abstract

dc:description

Background/Objectives: MINOCA is an enigmatic clinical entity with heterogeneous pathophysiological substrate and guarded prognosis. Overactivation of the sympathetic nervous system (SNS) has been implicated in adverse outcomes across various cardiovascular conditions, particularly in acute coronary syndromes. However, evidence regarding the role of SNS activity in MINOCA remains limited. However, data are scarse regarding MINOCA. The aim of our study is to assess the effect of SNS in the long-term prognosis of MINOCA patients and present data from the current clinical practice. Methods: 151 patients were included in the study after exclusion of 27 patients with myocarditis and other diagnoses. A cardiac magnetic resonance (CMR) performed at 123/151 patients demonstrated an ischemic pattern of late gadolinium enhancement (LGE) confirming the diagnosis of true AMI in 42 cases (28%). Based on multimodality imaging and clinical judgement, TTS was diagnosed in 55 patients (36%), whereas CMR failed to reveal abnormal findings in 54 cases (36%), categorized as MINOCA of unknown origin. Data were collected regarding clinical, imaging, angiographic parameters as well as various indices of sympathetic nervous system (SNS) activity. Patients were followed-up for 2 years in order to assess the cardiovascular prognosis.Results: Follow-up data were collected for 129 patients within 24 months. Major adverse cardiovascular events (MACEs) occurred in 31 patients of the total population, specifically in 10 patients with TTS (22%) and 21 patients with MINOCA (25%), with a median time from discharge to the first cardiovascular event 120 days (range 19–750). A total of 4 deaths were recorded, 3 of which were due to cardiovascular causes. No significant differences were observed in the incidence or type of MACEs between MINOCA and TTSCMR led to a final diagnosis reconsideration in up to 21% of patients. Among all the markers used to assess SNS activity, only MSNA appeared to be a prognostic indicator for the composite endpoint of MACEs in the overall population, in a multivariate model adjusted for age, sex, LVEF, and peak troponin (OR 1.086, 95% CI: 1.022–1.153, p = 0.008). Conclusions: Our study results suggest that SNS overactivation is associated with worse cardiovascular outcomes in MINOCA. However, more robust data from large scale trials are required for definite conclusions.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2025

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Mantzouranis, Panagiotis-Emmanouil
  • Μαντζουράνης, Παναγιώτης-Εμμανουήλ

Subjects

dc:subject × 17

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/59104

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Mantzouranis, Panagiotis-Emmanouil; Μαντζουράνης, Παναγιώτης-Εμμανουήλ. Ο τόνος του συμπαθητικού νευρικού συστήματος ως προγνωστικός δείκτης καρδιαγγειακής νοσηρότητας και θνητότητας σε ασθενείς με έμφραγμα του μυοκαρδίου χωρίς απόφραξη στεφανιαίων αγγείων (MINOCA). National and Kapodistrian University of Athens, 2025. http://hdl.handle.net/10442/hedi/59104